Sagara Hospital
About Sagara Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Pfizer
6
Eli Lilly and Company
3
Puma Biotechnology, Inc.
2
ETOP IBCSG Partners Foundation
1
Genentech, Inc.
1
Kyoto Breast Cancer Research Network
1
Kyowa Kirin Co., Ltd.
1
Clinical Trials at Sagara Hospital
During the past decade, Sagara Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 15 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer
2012-10-19
2018-10-25
Completed
61
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sagara Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Pfizer" with 6 trials
sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored and "ETOP IBCSG Partners Foundation"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sagara Hospital"
#1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Sagara Hospital
According to Clinical.Site data, the most researched conditions in "Sagara Hospital" are
"Breast Cancer" (8 trials), "Breast Neoplasms" (5 trials), "Metastatic Breast Cancer" (3 trials), "Neoplasms" (2 trials) and "Triple Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Sagara Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sagara Hospital
Most popular intervention types in "Sagara Hospital" are "Drug" (23 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (6 trials), "Placebo" (6 trials), "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials) and "Abemaciclib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sagara Hospital
The vast majority of trials in "Sagara Hospital" are
14 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Sagara Hospital
Currently, there are NaN active trials in "Sagara Hospital".
undefined are not yet recruiting,
1 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Sagara Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sagara Hospital, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".